Search research articles
Contact Us
Filters
Showing results (401-410 of 531) with videos related to
Page
of 54
Sort By:
The Journal of Infectious Diseases
|
February 1, 1996
Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope
A Beretta, S H Weiss, G Rappocciolo, et al.
The Journal of Infectious Diseases
|
August 1, 1994
Demonstration of human T lymphotropic virus type I (HTLV-I)-specific T cell responses from seronegative and polymerase chain reaction-negative persons exposed to HTLV-I
M Nishimura, A G Kermode, M Clerici, et al.
Infection Control and Hospital Epidemiology
|
July 8, 1999
Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers
R D'Amico, L A Pinto, P Meyer, et al.
The Journal of Clinical Investigation
|
April 1, 1989
Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals
H Golding, G M Shearer, K Hillman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 6, 1994
Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis
M Clerici, A Sarin, R L Coffman, et al.
AIDS (London, England)
|
January 6, 1999
Protease inhibitor and triple-drug therapy: cellular immune parameters are not restored in pediatric AIDS patients after 6 months of treatment
C Chougnet, K R Fowke, B U Mueller, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Pulmonary fibroblast activation during <i>Aspergillus fumigatus</i> infection enhances lung defense via immunomodulation and tissue remodeling
José P Guirao-Abad, Shannon M Shearer, Jon Bowden, et al.
BMC Infectious Diseases
|
January 17, 2023
Real-time analysis of hospital length of stay in a mixed SARS-CoV-2 Omicron and Delta epidemic in New South Wales, Australia
Ruarai J Tobin, James G Wood, Duleepa Jayasundara, et al.
Blood
|
December 9, 2004
TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells
Jean-Philippe Herbeuval, Adriano Boasso, Jean-Charles Grivel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1990
An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes
A Hosmalin, M Clerici, R Houghten, et al.
Page
of 54
Search research articles
Search
Showing results (401-410 of 531) with videos related to
Sort By:
Page
of 54
The Journal of Infectious Diseases
|
February 1, 1996
Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope
A Beretta, S H Weiss, G Rappocciolo, et al.
The Journal of Infectious Diseases
|
August 1, 1994
Demonstration of human T lymphotropic virus type I (HTLV-I)-specific T cell responses from seronegative and polymerase chain reaction-negative persons exposed to HTLV-I
M Nishimura, A G Kermode, M Clerici, et al.
Infection Control and Hospital Epidemiology
|
July 8, 1999
Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers
R D'Amico, L A Pinto, P Meyer, et al.
The Journal of Clinical Investigation
|
April 1, 1989
Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals
H Golding, G M Shearer, K Hillman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 6, 1994
Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis
M Clerici, A Sarin, R L Coffman, et al.
AIDS (London, England)
|
January 6, 1999
Protease inhibitor and triple-drug therapy: cellular immune parameters are not restored in pediatric AIDS patients after 6 months of treatment
C Chougnet, K R Fowke, B U Mueller, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Pulmonary fibroblast activation during <i>Aspergillus fumigatus</i> infection enhances lung defense via immunomodulation and tissue remodeling
José P Guirao-Abad, Shannon M Shearer, Jon Bowden, et al.
BMC Infectious Diseases
|
January 17, 2023
Real-time analysis of hospital length of stay in a mixed SARS-CoV-2 Omicron and Delta epidemic in New South Wales, Australia
Ruarai J Tobin, James G Wood, Duleepa Jayasundara, et al.
Blood
|
December 9, 2004
TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells
Jean-Philippe Herbeuval, Adriano Boasso, Jean-Charles Grivel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1990
An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes
A Hosmalin, M Clerici, R Houghten, et al.
Page
of 54